Literature DB >> 18456752

Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

C Haie-Meder1, P Morice, M Castiglione.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456752     DOI： 10.1093/annonc/mdn112

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Pathologic complete remission after preoperative high-dose-rate brachytherapy in patients with operable cervical cancer: preliminary results of a prospective randomized multicenter study.

Authors:  Julia Vízkeleti; Ildikó Vereczkey; Georgina Fröhlich; Szilvia Varga; Katalin Horváth; Tamás Pulay; Imre Pete; Csaba Nemeskéri; Árpád Mayer; Norbert Sipos; Miklós Kásler; Csaba Polgár
Journal:  Pathol Oncol Res       Date:  2014-07-11       Impact factor: 3.201

2.  Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer.

Authors:  Eun-Sun Choi; Jeong-Seok Nam; Ji-Youn Jung; Nam-Pyo Cho; Sung-Dae Cho
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.